Literature DB >> 23504091

Rodent models for mania: practical approaches.

N Z Kara1, H Einat.   

Abstract

The scarcity of good animal models for bipolar disorder (BPD) and especially for mania is repeatedly mentioned as one of the rate-limiting factors in the process of gaining a better understanding into its pathophysiology and of developing better treatments. Standard models of BPD have some value but usually represent only one facet of the disease and have partial validity. A number of new approaches for modeling BPD and specifically mania have been suggested in the last few years and can be combined to improve models. These approaches include targeted mutation models representing reverse translation, the identification of advantageous strains for components of the disorder, a search for the most homologous species to address specific human pathology, and the exploration of individual differences of response including the separation between susceptible and resilient animals. Additionally, recent efforts have identified and developed new tests to distinguish between "normal" and "BPD-like" animals including the different utilization of known tests and novel tests such as the female-urine-sniffing test and behavior pattern monitor analysis. Additional tests relating to further domains of BPD are still needed. An ideal model for BPD that will encompass the entire disease and be useful for every demand will probably not become available until we have a full understanding of the pathophysiology of the disorder. However, the current advances in modeling should lead to better comprehension of the disorder and therefore to the gradual development of increasingly improved models.

Entities:  

Mesh:

Year:  2013        PMID: 23504091     DOI: 10.1007/s00441-013-1594-x

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  8 in total

Review 1.  Investigating the mechanism(s) underlying switching between states in bipolar disorder.

Authors:  Jared W Young; Davide Dulcis
Journal:  Eur J Pharmacol       Date:  2015-03-23       Impact factor: 4.432

Review 2.  Tamoxifen use for the management of mania: a review of current preclinical evidence.

Authors:  Fernanda Armani; Monica Levy Andersen; José Carlos Fernandes Galduróz
Journal:  Psychopharmacology (Berl)       Date:  2014-01-18       Impact factor: 4.530

3.  In the era of whole-brain mapping for the exploration of mental disorders, we need to rethink our methods of rodent model establishment.

Authors:  Chuanjun Zhuo; Hongjun Tian; Jiayue Chen; Qianchen Li; Lei Yang; Xueqin Song; Yong Xu; Qinghua Luo; Weihua Yue; Chunhua Zhou
Journal:  Transl Psychiatry       Date:  2022-03-28       Impact factor: 7.989

4.  Abnormal development of monoaminergic neurons is implicated in mood fluctuations and bipolar disorder.

Authors:  Marin M Jukic; Tania Carrillo-Roa; Michal Bar; Gal Becker; Vukasin M Jovanovic; Ksenija Zega; Elisabeth B Binder; Claude Brodski
Journal:  Neuropsychopharmacology       Date:  2014-09-22       Impact factor: 7.853

Review 5.  Modeling mania in preclinical settings: A comprehensive review.

Authors:  Ajaykumar N Sharma; Gabriel R Fries; Juan F Galvez; Samira S Valvassori; Jair C Soares; André F Carvalho; Joao Quevedo
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2015-11-04       Impact factor: 5.067

Review 6.  Making Sense of Rodent Models of Anhedonia.

Authors:  Simona Scheggi; Maria Graziella De Montis; Carla Gambarana
Journal:  Int J Neuropsychopharmacol       Date:  2018-11-01       Impact factor: 5.176

Review 7.  Functional neuroanatomy of mania.

Authors:  Gonçalo Cotovio; Albino J Oliveira-Maia
Journal:  Transl Psychiatry       Date:  2022-01-24       Impact factor: 6.222

8.  Association of Polymorphism within the Putative miRNA Target Site in the 3'UTR Region of the DRD2 Gene with Neuroticism in Patients with Substance Use Disorder.

Authors:  Agnieszka Boroń; Małgorzata Śmiarowska; Anna Grzywacz; Krzysztof Chmielowiec; Jolanta Chmielowiec; Jolanta Masiak; Tomasz Pawłowski; Dariusz Larysz; Andrzej Ciechanowicz
Journal:  Int J Environ Res Public Health       Date:  2022-08-12       Impact factor: 4.614

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.